A Collaborative Study to Establish a Korea National Biological Standard for Antithrombin Concentrate

  • Kang, Hye-Na (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration) ;
  • Lee, Sung-Han (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Kim, Soon-Nam (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Hong, Choong-Man (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Lee, Ki-Hong (Blood Products Division, Boilogics Evaluation Department, Korea Food and Drug Administration, National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Oh, Ho-Jung (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Yoo, Si-Hyung (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Shin, In-Soo (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Choi, Seung-Eun (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Lee, Seok-Ho (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Gray, Elaine (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Okada, Yoshiaki (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases) ;
  • Hong, Seung-Hwa (National Institute for Biological Standards and Control, UK and National Institute of Infectious Diseases)
  • Published : 2002.10.01

Abstract

We have carried out collaborative study to evaluate a preparation of antithrombin concentrate whether or not it was suitable to serve as the candidate for a Korea National Biological Standard. Six laboratories. including three manufacturers and three National Control Laboratories. participated in this study. The potency of this candidate preparation was determined using the heparin cofactor chromogenic method. (omitted)

Keywords